„The connected lab”
Integration of automation and digitalization in the laboratory.
08:00 |
08:20 |
Registration |
||
08:30 |
08:40 |
Welcome by the Chairman of ELRIG.de e.V. |
Tobias May |
Elrig.de e.V. |
09:00 |
09:20 |
The Operating System for the Connected Lab: One Infrastructure for Data and Automation |
Lukas Bromig |
UniteLabs, Munich |
09:20 |
09:40 |
Connecting the nucleotides: Developing a DNA/RNA manufacturing pipeline from Nucleotides to RNA. |
Moritz Göttmann |
Biontech, Mainz |
09:40 |
10:00 |
Harnessing the benefits and data from acoustic liquid handlers and why there is a need to move beyond spreadsheets |
Marcus Oxer |
Titian Software Ltd, London, UK |
10:00 |
10:20 |
Bridging Legacy Workflows: From KNIME to MOSAIC for Enhanced Laboratory Automation |
David Garcia Lopez |
EU-Openscreen, Berlin |
10:20 |
10:40 |
Snapshots |
|
|
10:40 |
11:20 |
Coffee break & Poster Presentation |
|
|
11:20 |
11:40 |
2 million transcriptomes and beyond: Evotec high-throughput transcriptomics platform ScreenSeq™ for drug development |
Timur Samatov |
Evotec, Göttingen |
11:40 |
12:00 |
Mobile robotics in the lab – integration, standards and future trends |
Richard Rösch |
Fraunhofer IPA, Stuttgart |
12:00: |
13:20 |
Lunch Break & Poster Presentation |
|
|
13:20 |
13:40 |
Titel: "Computing the batch manufacture of custom DNA molecules.” |
Wladimir Labeikovsky |
Ribbon Biolabs, Wien, Austria |
13:40 |
14:00 |
|
Thomas Fürst |
Merck KGaA, Darmstadt |
14:00 |
14:20 |
„Functional Precision Oncology: Is this the real life? Is this just fantasy?” |
Christian Regenbrecht |
CELLphenomics, Berlin |
14:20 |
14:40 |
“Accelerating Merck's DMTA Cycle with Lab Digitalization and Automation” |
Sebastian Fuchs |
Merck KGaA, Darmstadt |
14:40 |
15:20 |
Coffee break & Postersession |
|
|
15:20 |
15:40 |
Digital Sustainability - A scalable approach for laboratory data management and integration |
Burkhard Schäfer |
Splashlake, Griesheim |
15:40 |
16:00 |
Snapshots |
|
|
16:00 |
16:20 |
|
|
CloudLabs, USA |
16:20 |
16:30 |
Wrap up Forum 2025 |
Arne Kusserow |
Merck KGaA |